Telomir Pharmaceuticals Inc share price logo

Telomir Pharmaceuticals Inc Share Price

NASDAQ: TELO

Small Cap

$1.34

as on

Telomir Pharmaceuticals Inc Stock Performance

as on March 18, 2026 at 6:57 am IST

  • Day's Low

    $1.30
    $1.34
    downward going graph

    2.99%

    Downside

  • 52 Week's Low

    52 Week's High

    $1.05
    $4.81
    downward going graph

    21.64%

    Downside

    258.58%

    Upside

    downward going graph

Telomir Pharmaceuticals Inc share price movements today

Previous Close
$1.34
Open
$1.31
Volume
233.5K
Day's Low - High
$1.30 - $1.34
52 Week Low - High
$1.05 - $4.81

Telomir Pharmaceuticals Inc Historical Returns

1 Month Return
+ 14.41 %
3 Month Return
-1.46 %
1 Year Return
-67.23 %
3 Year Return
0 %
5 Year Return
0 %

Telomir Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Telomir Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$46.1M

EPS (TTM)

-0.38

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-303.19%

Telomir Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Telomir Pharmaceuticals Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Telomir Pharmaceuticals Inc image
Telomir Pharmaceuticals Inc
NA$46.1MNANA0.00%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$42.3B128.81%136.878.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$118.4B116.77%30.432.94%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$33.5BNA117.745.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$80.0B59.91%18.2531.41%

Stock Returns calculator for Telomir Pharmaceuticals Inc Stock including INR - Dollar returns

The Telomir Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

Telomir Pharmaceuticals Inc investment value today

Current value as on today

₹39,591

Returns

₹60,409

(-60.41%)

Returns from Telomir Pharmaceuticals Inc Stock

₹67,476 (-67.48%)

Dollar Returns*

₹7,067 (+7.07%)

Telomir Pharmaceuticals Inc Stock’s Investor Sentiment and Interest

Search interest for Telomir Pharmaceuticals Inc Stock has decreased by -33% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-33% versus previous 30 day period

Telomir Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
-
-
-
-
-
-
18
-
-
-
Gross Profit
-
-
-
-1
-1
-6
9
-
-
-
Operating Income
-1
0
-1
-1
-1
-6
-2
-2
-5
-1
EBITDA
-1
0
-8
-1
-1
-5
-2
-2
-5
-1
Interest Expense
0
0
0
4
-
-
0
0
0
0
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-1
-1
-9
-6
-1
-5
-2
-2
-5
-1
Income Tax Expense
-1
0
-1
-1
-
-
-
-
-
-
Net Income
-1
-1
-9
-6
-1
-5
-2
-2
-5
-1
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
-15.42%
0.00%
0.00%
0.00%

Telomir Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

Sep 2021
Sep 2022
Sep 2023
Sep 2024
Total Revenue
-
-
-
-
Gross Profit
-
-
-3
-
Operating Income
0
0
-3
-12
EBITDA
0
0
-11
0
Interest Expense
-
-
1
4
Depreciation
-
-
-
-
Income Before Tax
0
0
-13
-16
Income Tax Expense
0
0
-2
-16
Net Income
0
0
-13
-16
Net Profit Margin
0.00%
0.00%
0.00%
0.00%

Telomir Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Net Income
-1
-9
-6
-1
-5
-2
-2
-5
-1
Operating Cash Flow
-2
-1
-1
-1
-1
0
0
0
0
Investing Cash Flow
-
-
-
-
-
-
-
-
-
Financing Cash Flow
1
1
5
0
0
1
-
1
7
Change in Cash
0
0
3
-1
-1
0
0
0
6

Telomir Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

Sep 2022
Sep 2023
Sep 2024
Net Income
0
-13
-16
Operating Cash Flow
0
-3
-5
Investing Cash Flow
-
-
-
Financing Cash Flow
0
3
6
Change in Cash
0
0
1

Insights on Telomir Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, TELO stock has moved up by 14.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 31.2% return, outperforming this stock by 98.4%

About Telomir Pharmaceuticals Inc

Telomir Pharmaceuticals, Inc. is a pre-clinical-stage pharmaceutical company. The Company is focused on the development of Telomir-1, a novel small molecule metal ion chelator and regulator designed to lengthen the DNA’s protective telomere caps, which are crucial in the aging process. Telomir 1 is being developed to protect stem cells by elongating and stimulating the telomeres to sustain self-renewal. Telomir-1 helps protect against age-related conditions, including Progeria (a rare genetic disorder that causes rapid aging in children), Wilson’s disease (a genetic disorder leading to toxic copper buildup in the body), and age-related macular degeneration (AMD), as well as Type 2 Diabetes, cancer, and Alzheimer’s disease. It is exploring the potential of Telomir-1 with ongoing research in animals and then in humans. It is focused on developing and commercializing TELOMIR-1, proposed to be dosed orally, with the aim of promoting longevity and enhancing overall quality of life.
OrganisationTelomir Pharmaceuticals Inc
Headquarters100 SE 2nd Street, Miami, FL, United States, 33131
CEOMr. Erez Aminov
E-voting on sharesClick here to vote

Key Management of Telomir Pharmaceuticals Inc

Name

Title

Mr. Erez Aminov

Chairman of the Board & CEO

Mr. Alan Weichselbaum CPA, M.B.A.

Chief Financial Officer

Dr. Itzchak Angel Ph.D.

Chief Scientific Advisor

FAQs

What is Telomir Pharmaceuticals Inc share price today?

Telomir Pharmaceuticals Inc share price today is $1.34 as on at the close of the market. Telomir Pharmaceuticals Inc share today touched a day high of $1.34 and a low of $1.3.

What is the 52 week high and 52 week low for Telomir Pharmaceuticals Inc share?

Telomir Pharmaceuticals Inc share touched a 52 week high of $4.81 on and a 52 week low of $1.05 on . Telomir Pharmaceuticals Inc stock price today i.e. is closed at $1.34,which is 72.11% down from its 52 week high and 27.62% up from its 52 week low.

What is Telomir Pharmaceuticals Inc 's market capitalisation today?

Telomir Pharmaceuticals Inc market capitalisation is $0.00T as on .

How to invest in Telomir Pharmaceuticals Inc Stock (TELO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Telomir Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Telomir Pharmaceuticals Inc Shares that will get you 1.1194 shares as per Telomir Pharmaceuticals Inc share price of $1.34 per share as on March 18, 2026 at 1:27 am IST.

What is the minimum amount required to buy Telomir Pharmaceuticals Inc Stock (TELO) from India?

Indian investors can start investing in Telomir Pharmaceuticals Inc (TELO) shares with as little as ₹92.634 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹926.34 in Telomir Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Telomir Pharmaceuticals Inc share’s latest price of $1.34 as on March 18, 2026 at 1:27 am IST, you will get 7.4627 shares of Telomir Pharmaceuticals Inc . Learn more about fractional shares .